SCHEMBL4650978

SCHEMBL4650978

CN(C)S(=O)(=O)n1ccc(C2CC2)n1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
ALDH1A1 P00352 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HCRTR2 O43614 3/20 0.33
HTT P42858 2/20 0.33
JAK2 O60674 1/20 0.32
TYK2 P29597 1/20 0.32
JAK3 P52333 1/20 0.32
DDB1 Q16531 1/20 0.31
CRBN Q96SW2 1/20 0.31
MEN1 O00255 3/20 0.31
KMT2A Q03164 3/20 0.31
PARP1 P09874 1/20 0.30
KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12128393 0.73 HTT (0.47) SMN1; SMN2NPC1RAB9AALDH1A1L3MBTL1
SCHEMBL25360339 0.72 MEN1 (0.37) SMN1; SMN2HTTCRBNMEN1KMT2A
SCHEMBL535681 0.72 HTT (0.36) SMN1; SMN2HTTMEN1KMT2AKDM4E
SCHEMBL959784 0.72 MEN1 (0.37) SMN1; SMN2ALDH1A1L3MBTL1HTTMEN1
SCHEMBL23536405 0.71 HTR2C (0.39) SMN1; SMN2NPC1RAB9AALDH1A1HTT
SCHEMBL14901206 0.69 HTT (0.34) SMN1; SMN2ALDH1A1HTTMEN1KMT2A
SCHEMBL2158360 0.69 HTT (0.34) SMN1; SMN2HTTMEN1KMT2A
SCHEMBL3024635 0.69 SMN1; SMN2 (0.35) SMN1; SMN2HTTMEN1KMT2AKDM4E
SCHEMBL16125119 0.69 SORD (0.37) SMN1; SMN2ALDH1A1HTTMEN1KMT2A
SCHEMBL877521 0.68 CRBN (0.35) NPC1RAB9AALDH1A1L3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904451-A1 ARYL-ALKYLAMINES AND HETEROARYL-ALKYLAMINES AS PROTEIN KINASE INHIBITORS Astex Therapeutics Limited (GB) 2008-04-02 EP disclosed
WO-2006136830-A1 ARYL-ALKYLAMINES AND HETEROARYL-ALKYLAMINES AS PROTEIN KINASE INHIBITORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO disclosed